Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Champions Oncology, Inc. (CSBR) had Cost of Goods Sold of $7.27M for the most recently reported fiscal quarter, ending 2025-04-30.
| Income Statement Financials | |
$12.36M |
|
$-1.83M |
|
|
Cost of Goods Sold |
$7.27M |
$5.08M |
|
$14.36M |
|
$-2.01M |
|
$0.04M |
|
$-1.97M |
|
$-1.97M |
|
$-1.83M |
|
$-1.83M |
|
$-1.83M |
|
$-1.83M |
|
$-2.01M |
|
$-1.61M |
|
13.66M |
|
14.27M |
|
$-0.14 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$22.37M |
|
$4.38M |
|
$9.97M |
|
$32.34M |
|
$23.85M |
|
-- |
|
$4.72M |
|
$28.57M |
|
$3.77M |
|
$3.44M |
|
$3.77M |
|
13.78M |
|
| Cash Flow Statement Financials | |
$7.39M |
|
$-0.39M |
|
$0.17M |
|
$2.62M |
|
$9.79M |
|
$7.17M |
|
$0.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
41.14% |
|
-16.24% |
|
-16.24% |
|
-- |
|
-15.90% |
|
-14.85% |
|
$7.00M |
|
-- |
|
-- |
|
-- |
|
0.38 |
|
-- |
|
1.10 |
|
81.83 |
|
-48.65% |
|
-53.39% |
|
-5.67% |
|
-48.65% |
|
$0.27 |
|
$0.49 |
|
$0.52 |
|